// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Number of Worrisome Features Is Associated with Increasing Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)

P. Zelga - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Intraductal papillary mucinous neoplasm

N/A

ABO Blood Group and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms

P. Zelga - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mucinous neoplasms

N/A

Differential Expression of ER-α and ER-β in Pancreatic Neoplasms: A Case-Matched Study

P. Lykoudis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Network Meta-Analysis Comparing Gastric Resection Approaches and Enteric Anastomotic Configurations on Delayed Gastric Emptying Following Pancreaticoduodenectomy

S. Bhat - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroparesis

N/A

Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients with Resected Ampullary Adenocarcinoma

D.H. Lemmers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ampullary adenocarcinoma

N/A

Metabolites Levels Correlate to Tumour Stage and Survival in Pancreatic Ductal Adenocarcinoma Patients

N. Elebo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreas ductal adenocarcinoma

N/A

Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

The Influence of Procedural Volume on Short-Term Outcomes for Robotic Pancreaticoduodenectomy

M. Kawka - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Robotic versus Laparoscopic Distal Pancreatectomy for Upfront Resectable Pancreatic Cancer: An International Retrospective Cohort Study

J.W. Chen - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Postoperative Enteral versus Parenteral Nutrition in Pancreaticoduodenectomy: Effect on Long-Term Survival

Z. Habib - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Impact of Routine Nasogastric Decompression versus No Nasogastric Decompression after Pancreatoduodenectomy on Perioperative Outcomes: A Meta-Analysis

C. Varghese - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Fast-Track Surgery Programme Leads to Timelier Treatment and Higher Resection Rates in Pancreatic Cancer

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreato-biliary malignancies

N/A

Quality of Life after Pancreatic Surgery - A Systematic Review

N. James - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Improving Outcomes Amongst Patients with Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy

J. Halle-Smith - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Systematic Review of the Incidence and Risk Factors for Chyle Leak after Pancreatic Surgery

C. Varghese - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes Following Pancreatoduodenectomy in Octogenarians in Scotland

M. Hughes - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroparesis

N/A

Changes in Pancreatoduodenectomy over Three Decades to Predict Future Pathological and Operative Complexity

J. Halle-Smith - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interpreting Trends in Post-operative Drain Fluid Amylase According to Type of Anastomosis Used to Form a Pancreaticojejunostomy

E. Britton - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Casting a Wider NET: Defining Pancreatic Exocrine Insufficiency in Patients with Neuroendocrine Tumours using the 13C-Mixed-Triglyceride Breath Test

L. Hall - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ergocalciferol

Parasympathetic Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker Predicting Oncological Outcome in Perihilar Cholangiocarcinoma

J. Bednarsch - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Advanced biliary tract carcinoma

N/A

Copyright © 2026. QuantiNova All rights reserved